scispace - formally typeset
Open AccessJournal ArticleDOI

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

Reads0
Chats0
TLDR
It is shown for the first time that repeated ketamine administration is effective in sustaining initial antidepressant effects observed after single dosing, in patients with treatment-resistant depression.
About
This article is published in Pharmacological Reports.The article was published on 2020-04-16 and is currently open access. It has received 57 citations till now. The article focuses on the topics: Randomized controlled trial & Ketamine.

read more

Citations
More filters
Journal ArticleDOI

The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses

TL;DR: After more than half a century of research, thousands of RCTs and millions of invested funds, the effect sizes of psychotherapy and pharmacotherapies for mental disorders are limited, suggesting a ceiling effect for treatment research as presently conducted.
Journal ArticleDOI

Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.

TL;DR: In this article, the authors identified nuclear receptor-binding protein 1 (NRBP1) that could contribute to different antidepressant-like effects of the two enantiomers in chronic social defeat stress (CSDS) model.
Journal ArticleDOI

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments

TL;DR: The therapeutic mechanisms behind both conventional and psychedelic paradigms, including the evolution of this knowledge and the associated explanatory frameworks are reviewed, and how psychedelics have provided insights about psychiatric illnesses and treatments over the past decades are explored.
Journal ArticleDOI

Ketamine and the Future of Rapid-Acting Antidepressants.

TL;DR: The history of antidepressant treatment advances that preceded the ketamine discovery are reviewed, mechanistic hypotheses for how ketamine may exert its antidepressant effects are critically examined, and the impact this knowledge has had on ongoing drug discovery efforts are discussed.
Journal ArticleDOI

Depression: Biological markers and treatment.

TL;DR: An overview of the role of major stress response system, the HPA axis, and its dysregulation in depression, possible involvement of neurotrophins, especially brain-derived neurotrophic factor, glial cell line- derived neurotrophicfactor and insulin-like growth factor-1 are provided.
References
More filters
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Journal ArticleDOI

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Theo Vos, +778 more
- 16 Sep 2017 - 
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
Journal ArticleDOI

Global, regional, and national incidence, prevalence, andyears lived with disability for 354 diseases and injuries for195 countries and territories, 1990–2017: a systematicanalysis for the Global Burden of Disease Study 2017

TL;DR: All-cause age-standardised YLD rates decreased by 3·9% from 1990 to 2017; however, the all-age YLD rate increased by 7·2% while the total sum of global YLDs increased from 562 million (421–723) to 853 million (642–1100).
Related Papers (5)